Back to top
more

OPKO Health (OPK)

(Real Time Quote from BATS)

$1.20 USD

1.20
2,350,469

-0.03 (-2.44%)

Updated Apr 25, 2024 11:38 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (87 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Balance Sheet

Research for OPK

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for OPKO Health, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 96 153 135 72 85
Receivables 123 127 260 286 135
Notes Receivable 0 0 0 0 0
Inventories 66 74 87 132 53
Other Current Assets 25 40 342 32 51
Total Current Assets 309 395 823 523 324
Net Property & Equipment 75 83 80 141 127
Investments & Advances 16 28 11 16 21
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 1,339 1,419 842 1,156 1,201
Deposits & Other Assets 204 204 600 600 597
Total Assets 2,012 2,167 2,400 2,473 2,309
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 70 67 276 101 63
Current Portion Long-Term Debt 27 37 0 25 10
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 90 98 0 241 165
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 43 0 0
Total Current Liabilities 200 213 330 375 249
Mortgages 0 0 0 0 0
Deferred Taxes/Income 127 126 148 137 119
Convertible Debt 214 210 188 222 211
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 27 27 15 37 88
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 622 606 715 802 695
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 8 8 7 7 7
Capital Surplus 3,433 3,422 3,222 3,153 3,143
Retained Earnings -2,012 -1,823 -1,512 -1,482 -1,511
Other Equity -38 -43 -31 -4 -22
Treasury Stock 2 2 2 2 2
Total Shareholder's Equity 1,389 1,562 1,685 1,672 1,615
Total Liabilities & Shareholder's Equity 2,012 2,167 2,400 2,473 2,309
Total Common Equity 1,389 1,562 1,685 1,672 1,615
Shares Outstanding 773.20 772.60 681.30 670.00 665.60
Book Value Per Share 1.80 2.02 2.47 2.49 2.43

Fiscal Year End for OPKO Health, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 96 139 108 111
Receivables NA 123 117 211 121
Notes Receivable NA 0 0 0 0
Inventories NA 66 69 74 75
Other Current Assets NA 25 32 41 99
Total Current Assets NA 309 357 434 406
Net Property & Equipment NA 75 78 79 81
Investments & Advances NA 16 19 28 41
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 1,339 1,353 1,380 1,401
Deposits & Other Assets NA 204 204 204 203
Total Assets NA 2,012 2,057 2,159 2,170
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 30 29 24
Accounts Payable NA 70 67 88 81
Current Portion Long-Term Debt NA 27 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 90 92 99 106
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 200 201 226 222
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 127 138 133 130
Convertible Debt NA 214 213 212 211
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 26 27 28
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 622 612 624 618
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 8 8 8 8
Capital Surplus NA 3,433 3,430 3,427 3,425
Retained Earnings NA -2,012 -1,945 -1,861 -1,841
Other Equity NA -38 -47 -37 -38
Treasury Stock NA 2 2 2 2
Total Shareholder's Equity NA 1,389 1,445 1,535 1,552
Total Liabilities & Shareholder's Equity NA 2,012 2,057 2,159 2,170
Total Common Equity 0 1,389 1,445 1,535 1,552
Shares Outstanding 696.90 773.20 773.00 773.00 772.60
Book Value Per Share 0.00 1.80 1.87 1.99 2.01